ReviewDiscover oncology2025

Progress of antibody-drug conjugates in the treatment of locally advanced or metastatic urothelial carcinoma: opportunities and challenges.

Fanhao Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.